Conor is a Commercialisation Executive within Imperial Enterprise, supporting innovations arising from the Faculty of Medicine.
Conor is a Commercialisation Executive within Imperial Enterprise, supporting innovations arising from the Faculty of Medicine.
A platform for rapidly generating antibodies against diverse bacterial targets, applicable to monoclonal antibody development and the expedited evaluation of potential vaccine antigens
Ryhan is a Junior Officer for Commercialisation at Imperial’s Faculty of Natural Sciences.
A model score calculated from levels of circulating plasma proteins for the diagnosis, prognosis, and treatment optimisation of Pulmonary Arterial Hypertension.
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.